Our objective was to assess the efficacy of a standard dose ifosfamide and doxorubicin containing regimen in the treatment of advanced soft tissue sarcomas. Forty consecutive patients with a median age of 35.5 years were treated. Ifosfamide was administered at a dose of 2.5 g/m 2 /day as 72-hour con
Ifosfamide, vincristine, doxorubicin and dacarbazine in adult patients with advanced soft-tissue sarcoma
β Scribed by Tom A. Wiklund; Carl P. Blomqvist; Martti Virolainen; Inkeri Elomaa
- Publisher
- Springer
- Year
- 1992
- Tongue
- English
- Weight
- 552 KB
- Volume
- 30
- Category
- Article
- ISSN
- 0344-5704
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
In a phase II study, 16 adult patients with locally advanced or metastatic soft tissue sarcomas were treated with i.v. infusions of ifosfamide/mesna 5 g/m2 plus i.v. doxorubicin 40 mg/m2. Courses were given every 3 weeks up to a maximum of six courses in responding patients. Six patients (37.5%) had
## Background: Standard therapy for pediatric nonrhabdomyosarcoma soft tissue sarcomas (pnrsts) consists of surgical resection with or without radiotherapy. the role of chemotherapy in the treatment of these tumors has not yet been defined. we investigated the efficacy and toxicity of an ifosfamide